Professor of Medicine
Director of Johns Hopkins Scleroderma Center
Dr. Wigley is a physician-scientist with a special interest in Raynaud’s phenomenon and systemic sclerosis (scleroderma). He has a particular interest in translational (bed to bench) research and during his years as Director (1992-2002) structured the Division to accomplish this goal. ch program. Dr. Wigley’s current research is focused on understanding the pathophysiology and clinical features of scleroderma. He is also interested in developing and testing novel treatments for Raynaud’s phenomenon and scleroderma.
The Scleroderma Center was founded by Dr Wigley with Dr Barbara White from the University of Maryland and Dr. Robert Wise from the Johns Hopkins Division of Pulmonary Medicine. Currently, the Center is one of the largest and most active Scleroderma Research Centers in the world seeing over 175 new scleroderma patients a year.
(top of page)
